Antibody Engineering & Therapeutics Europe is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Andrew Martin, D.Phil.
Professor of Bioinformatics and Computational Biology at University College London


Andrew C.R. Martin did his undergraduate degree in Biochemistry at the University of Oxford where he stayed for his D.Phil. with Anthony R. Rees. During his D.Phil., he developed the first automated approach for antibody modelling which was later commercialized by Oxford Molecular as AbM. After a brief stint an the UK National Institute for Medical Research, a few years self-employed as a scientific software developer and spending some time at the DKfz in Heidelberg, he joined Janet Thornton's group at UCL where he continued to work on antibodies and protein loops. He spent a year as technical director at UCL spinout Inpharmatica before moving to the University of Reading and back to UCL in 2004. His research focuses on development of computational tools for working with antibody sequence and structure including antibody modelling, humanization and prediction of antibody stability. He has developed the widely-used abYsis antibody database and workbench.

Andrew Martin, D.Phil.'s Network

Agenda Sessions

  • Co-Chairs Remarks


Speakers at this event